These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 30904939)

  • 1. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
    Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
    Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study.
    Gao Y; Zhao T; Lv N; Liu S; Yuan T; Fu Y; Zhao W; Zhu B
    Endocrine; 2024 Sep; 85(3):1178-1192. PubMed ID: 38761345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
    DeFronzo RA; Buse JB; Kim T; Burns C; Skare S; Baron A; Fineman M
    Diabetologia; 2016 Aug; 59(8):1645-54. PubMed ID: 27216492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes.
    Gormsen LC; Søndergaard E; Christensen NL; Brøsen K; Jessen N; Nielsen S
    Diabetologia; 2019 Jul; 62(7):1251-1256. PubMed ID: 30976851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of
    Shin NR; Gu N; Choi HS; Kim H
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of drinking water pH on the human gut microbiota and glucose regulation: results of a randomized controlled cross-over intervention.
    Hansen TH; Thomassen MT; Madsen ML; Kern T; Bak EG; Kashani A; Allin KH; Hansen T; Pedersen O
    Sci Rep; 2018 Nov; 8(1):16626. PubMed ID: 30413727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
    Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
    Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
    Zhang X; Ren H; Zhao C; Shi Z; Qiu L; Yang F; Zhou X; Han X; Wu K; Zhong H; Li Y; Li J; Ji L
    Diabetologia; 2022 Oct; 65(10):1613-1626. PubMed ID: 35930018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
    Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
    PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
    Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
    BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X; Wang Y; Huang L; Guo P; Zhang S; Sun Y; Jin M
    Front Endocrinol (Lausanne); 2024; 15():1397034. PubMed ID: 39257903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant intestinal microbiota in individuals with prediabetes.
    Allin KH; Tremaroli V; Caesar R; Jensen BAH; Damgaard MTF; Bahl MI; Licht TR; Hansen TH; Nielsen T; Dantoft TM; Linneberg A; Jørgensen T; Vestergaard H; Kristiansen K; Franks PW; ; Hansen T; Bäckhed F; Pedersen O
    Diabetologia; 2018 Apr; 61(4):810-820. PubMed ID: 29379988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity.
    Van Meijel RLJ; Venema K; Canfora EE; Blaak EE; Goossens GH
    Benef Microbes; 2022 Oct; 13(4):355-364. PubMed ID: 35866596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents.
    Almugadam BS; Liu Y; Chen SM; Wang CH; Shao CY; Ren BW; Tang L
    J Diabetes Res; 2020; 2020():7253978. PubMed ID: 33062716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.